Ghent University Academic Bibliography

Advanced

MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

J Bousquet, HJ Schunemann, J Fonseca, B Samolinski, Claus Bachert UGent, GW Canonica, T Casale, AA Cruz, P Demoly, P Hellings, et al. (2015) ALLERGY. 70(11). p.1372-1392
abstract
Several unmet needs have been identified in allergic rhinitis: identification of the time of onset of the pollen season, optimal control of rhinitis and comorbidities, patient stratification, multidisciplinary team for integrated care pathways, innovation in clinical trials and, above all, patient empowerment. MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) is a simple system centred around the patient which was devised to fill many of these gaps using Information and Communications Technology (ICT) tools and a clinical decision support system (CDSS) based on the most widely used guideline in allergic rhinitis and its asthma comorbidity (ARIA 2015 revision). It is one of the implementation systems of Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA). Three tools are used for the electronic monitoring of allergic diseases: a cell phone-based daily visual analogue scale (VAS) assessment of disease control, CARAT (Control of Allergic Rhinitis and Asthma Test) and e-Allergy screening (premedical system of early diagnosis of allergy and asthma based on online tools). These tools are combined with a clinical decision support system (CDSS) and are available in many languages. An e-CRF and an e-learning tool complete MASK. MASK is flexible and other tools can be added. It appears to be an advanced, global and integrated ICT answer for many unmet needs in allergic diseases which will improve policies and standards.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
ARIA, Information and communications technology, asthma, CLIMATE-CHANGE, POLLEN COUNTS, DECISION-SUPPORT-SYSTEMS, INTEGRATED CARE PATHWAYS, WORLD-HEALTH-ORGANIZATION, RANDOMIZED CONTROLLED-TRIAL, CHRONIC RESPIRATORY-DISEASES, EUROPEAN INNOVATION PARTNERSHIP, MACVIA-LR, VISUAL ANALOG SCALES, QUALITY-OF-LIFE, allergic rhinitis
journal title
ALLERGY
Allergy
volume
70
issue
11
pages
1372 - 1392
Web of Science type
Article
Web of Science id
000363329400003
JCR category
ALLERGY
JCR impact factor
6.335 (2015)
JCR rank
2/25 (2015)
JCR quartile
1 (2015)
ISSN
0105-4538
DOI
10.1111/all.12686
project
Ghent researchers on unfolded proteins in inflammatory disease (GROUP-ID)
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
6981781
handle
http://hdl.handle.net/1854/LU-6981781
date created
2015-11-13 16:54:15
date last changed
2016-12-19 15:42:05
@article{6981781,
  abstract     = {Several unmet needs have been identified in allergic rhinitis: identification of the time of onset of the pollen season, optimal control of rhinitis and comorbidities, patient stratification, multidisciplinary team for integrated care pathways, innovation in clinical trials and, above all, patient empowerment. MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) is a simple system centred around the patient which was devised to fill many of these gaps using Information and Communications Technology (ICT) tools and a clinical decision support system (CDSS) based on the most widely used guideline in allergic rhinitis and its asthma comorbidity (ARIA 2015 revision). It is one of the implementation systems of Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA). Three tools are used for the electronic monitoring of allergic diseases: a cell phone-based daily visual analogue scale (VAS) assessment of disease control, CARAT (Control of Allergic Rhinitis and Asthma Test) and e-Allergy screening (premedical system of early diagnosis of allergy and asthma based on online tools). These tools are combined with a clinical decision support system (CDSS) and are available in many languages. An e-CRF and an e-learning tool complete MASK. MASK is flexible and other tools can be added. It appears to be an advanced, global and integrated ICT answer for many unmet needs in allergic diseases which will improve policies and standards.},
  author       = {Bousquet, J and Schunemann, HJ and Fonseca, J and Samolinski, B and Bachert, Claus and Canonica, GW and Casale, T and Cruz, AA and Demoly, P and Hellings, P and Valiulis, A and Wickman, M and Zuberbier, T and Bosnic-Anticevitch, S and Bedbrook, A and Bergmann, KC and Caimmi, D and Dahl, R and Fokkens, WJ and Grisle, I and Lodrup Carlsen, K and Mullol, J and Muraro, A and Palkonen, S and Papadopoulos, N and Passalacqua, G and Ryan, D and Valovirta, E and Yorgancioglu, A and Aberer, W and Agache, I and Adachi, M and Akdis, CA and Akdis, M and Annesi-Maesano, I and Ansotegui, IJ and Anto, JM and Arnavielhe, S and Arshad, H and Baiardini, I and Baigenzhin, AK and Barbara, C and Bateman, ED and Beghe, B and Bel, EH and Ben Kheder, A and Bennoor, KS and Benson, M and Bewick, M and Bieber, T and Bindslev-Jensen, C and Bjermer, L and Blain, H and Boner, AL and Boulet, LP and Bonini, M and Bonini, S and Bosse, I and Bourret, R and Bousquet, PJ and Braido, F and Briggs, AH and Brightling, CE and Brozek, J and Buhl, R and Burney, PG and Bush, A and Caballero-Fonseca, F and Calderon, MA and Camargos, PAM and Camuzat, T and Carlsen, KH and Carr, W and Sarabia, AMC and Chavannes, NH and Chatzi, L and Chen, YZ and Chiron, R and Chkhartishvili, E and Chuchalin, AG and Ciprandi, G and Cirule, I and de Sousa, JC and Cox, L and Crooks, G and Costa, DJ and Custovic, A and Dahlen, SE and Darsow, U and De Carlo, G and De Blay, F and Dedeu, T and Deleanu, D and Denburg, JA and Devillier, P and Didier, A and Dinh-Xuan, AT and Dokic, D and Douagui, H and Dray, G and Dubakiene, R and Durham, SR and Dykewicz, MS and El-Gamal, Y and Emuzyte, R and Wagner, AF and Fletcher, M and Fiocchi, A and Forastiere, F and Gamkrelidze, A and Gemicioglu, B and Gereda, JE and Diaz, SG and Gotua, M and Grouse, L and Guzman, MA and Haahtela, T and Hellquist-Dahl, B and Heinrich, J and Horak, F and Hourihane, JOB and Howarth, P and Humbert, M and Hyland, ME and Ivancevich, JC and Jares, EJ and Johnston, SL and Joos, G and Jonquet, O and Jung, KS and Just, J and Kaidashev, I and Kalayci, O and Kalyoncu, AF and Keil, T and Keith, PK and Khaltaev, N and Klimek, L and N'Goran, BK and Kolek, V and Koppelman, GH and Kowalski, ML and Kull, I and Kuna, P and Kvedariene, V and Lambrecht, Bart and Lau, S and Larenas-Linnemann, D and Laune, D and Le, LTT and Lieberman, P and Lipworth, B and Li, J and Louis, R and Magard, Y and Magnan, A and Mahboub, B and Majer, I and Makela, MJ and Manning, P and Keenoy, ED and Marshall, GD and Masjedi, MR and Maurer, M and Mavale-Manuel, S and Melen, E and Melo-Gomes, E and Meltzer, EO and Merk, H and Miculinic, N and Mihaltan, F and Milenkovic, B and Mohammad, Y and Molimard, M and Momas, I and Montilla-Santana, A and Morais-Almeida, M and Mosges, R and Namazova-Baranova, L and Naclerio, R and Neou, A and Neffen, H and Nekam, K and Niggemann, B and Nyembue, TD and O'Hehir, RE and Ohta, K and Okamoto, Y and Okubo, K and Ouedraogo, S and Paggiaro, P and Pali-Scholl, I and Palmer, S and Panzner, P and Papi, A and Park, HS and Pavord, I and Pawankar, R and Pfaar, O and Picard, R and Pigearias, B and Pin, I and Plavec, D and Pohl, W and Popov, TA and Portejoie, F and Postma, D and Potter, P and Price, D and Rabe, KF and Raciborski, F and Pontal, FR and Repka-Ramirez, S and Robalo-Cordeiro, C and Rolland, C and Rosado-Pinto, J and Reitamo, S and Rodenas, F and Roman Rodriguez, M and Romano, A and Rosario, N and Rosenwasser, L and Rottem, M and Sanchez-Borges, M and Scadding, GK and Serrano, E and Schmid-Grendelmeier, P and Sheikh, A and Simons, FER and Sisul, JC and Skrindo, I and Smit, HA and Sole, D and Sooronbaev, T and Spranger, O and Stelmach, R and Strandberg, T and Sunyer, J and Thijs, C and Todo-Bom, A and Triggiani, M and Valenta, R and Valero, AL and van Hage, M and Vandenplas, O and Vezzani, G and Vichyanond, P and Viegi, G and Wagenmann, M and Walker, S and Wang, DY and Wahn, U and Williams, DM and Wright, J and Yawn, BP and Yiallouros, PK and Yusuf, OM and Zar, HJ and Zernotti, ME and Zhang, L and Zhong, N and Zidarn, M and Mercier, J},
  issn         = {0105-4538},
  journal      = {ALLERGY},
  keyword      = {ARIA,Information and communications technology,asthma,CLIMATE-CHANGE,POLLEN COUNTS,DECISION-SUPPORT-SYSTEMS,INTEGRATED CARE PATHWAYS,WORLD-HEALTH-ORGANIZATION,RANDOMIZED CONTROLLED-TRIAL,CHRONIC RESPIRATORY-DISEASES,EUROPEAN INNOVATION PARTNERSHIP,MACVIA-LR,VISUAL ANALOG SCALES,QUALITY-OF-LIFE,allergic rhinitis},
  language     = {eng},
  number       = {11},
  pages        = {1372--1392},
  title        = {MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation},
  url          = {http://dx.doi.org/10.1111/all.12686},
  volume       = {70},
  year         = {2015},
}

Chicago
Bousquet, J, HJ Schunemann, J Fonseca, B Samolinski, Claus Bachert, GW Canonica, T Casale, et al. 2015. “MACVIA-ARIA Sentinel NetworK for Allergic Rhinitis (MASK-rhinitis): The New Generation Guideline Implementation.” Allergy 70 (11): 1372–1392.
APA
Bousquet, J, Schunemann, H., Fonseca, J., Samolinski, B., Bachert, C., Canonica, G., Casale, T., et al. (2015). MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. ALLERGY, 70(11), 1372–1392.
Vancouver
1.
Bousquet J, Schunemann H, Fonseca J, Samolinski B, Bachert C, Canonica G, et al. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. ALLERGY. 2015;70(11):1372–92.
MLA
Bousquet, J, HJ Schunemann, J Fonseca, et al. “MACVIA-ARIA Sentinel NetworK for Allergic Rhinitis (MASK-rhinitis): The New Generation Guideline Implementation.” ALLERGY 70.11 (2015): 1372–1392. Print.